Predicting The Risk Of Cardiovascular Complications In Patients With Psoriatic Arthritis

dc.contributor.author	Abdullaev U.S
dc.date.accessioned	2026-01-02T11:34:00Z
dc.date.issued	2024-12-08
dc.description.abstract	According to modern researchers, one of the most common comorbid diseases in patients with psoriatic arthritis (PsA) is cardiovascular pathology (CVP). The trend frequency of cardiovascular pathology (CVP) has a high probability of developing cardiovascular complications (CVC), which leads to early disability in PsA patients. This is the reason for in-depth analysis of risk factors and predicting the risk of cardiovascular complications (CVC) in PsA patients.
dc.format	application/pdf
dc.identifier.uri	https://geniusjournals.org/index.php/emrp/article/view/6513
dc.identifier.uri	https://asianeducationindex.com/handle/123456789/77855
dc.language.iso	eng
dc.publisher	Genius Journals
dc.relation	https://geniusjournals.org/index.php/emrp/article/view/6513/5413
dc.rights	https://creativecommons.org/licenses/by-nc/4.0
dc.source	Eurasian Medical Research Periodical; Vol. 39 (2024): EMRP; 1-4
dc.source	2795-7624
dc.subject	Psoriatic arthritis
dc.subject	cardiovascular complications
dc.subject	cardiovascular pathology
dc.title	Predicting The Risk Of Cardiovascular Complications In Patients With Psoriatic Arthritis
dc.type	info:eu-repo/semantics/article
dc.type	info:eu-repo/semantics/publishedVersion
dc.type	Peer-reviewed Article

item.page.files

pagination.showing.labelpagination.showing.detail

item.page.filesection.name: us_2024_predicting_the_risk_of_cardiovascular_co.pdf
item.page.filesection.size: 301.69 KB
item.page.filesection.format: Adobe Portable Document Format